The Distraction of Knee Joint to Alleviate osteoArthritic Pain (DiKAP) Trial
DiKAP
Efficacy of Adding Mechanical Nonsurgical Knee Traction to Standard Physical Therapy Rehabilitation of Knee Osteoarthritis: a Randomized Controlled Trial
1 other identifier
interventional
198
0 countries
N/A
Brief Summary
This is a randomized controlled trial examining the short- and long-term effects of mechanical nonsurgical knee joint traction on knee pain, function, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started Sep 2021
Typical duration for not_applicable knee-osteoarthritis
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2020
CompletedFirst Posted
Study publicly available on registry
April 2, 2020
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 10, 2021
March 1, 2021
1.2 years
March 29, 2020
March 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in pain score using the Arabic version of the Knee Injury and Osteoarthritis Outcome Score (KOOS)
A 5-point Likert scale comprised of 42 questions across 5 subscales. Standardized answers are assigned a score from 0 (no symptoms) to 4 (extreme symptoms). A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
Baseline, 2, 6 and 12 months follow-up
Change in physical function score using the Arabic version of the Knee Injury and Osteoarthritis Outcome Score (KOOS)
A 5-point Likert scale comprised of 42 questions across 5 subscales. Standardized answers are assigned a score from 0 (no symptoms) to 4 (extreme symptoms). A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
Baseline, 2, 6 and 12 months follow-up
Secondary Outcomes (8)
Change in knee pain using the Arabic version of the Numeric Pain Rating Scale (ANPRS)
Baseline, 2, 6 and 12 months follow-up
Change in Patient's Global Assessment
2, 6, 12 months follow-up
Change in Health-related Quality of Life score using the Arabic version of the Short Form 36 (SF-36) scale
Baseline, 2, 6 and 12 months follow-up
Change in the time taken to complete the Timed Up and Go (TUG)
Baseline, 2, 6 and 12 months follow-up
Change in the wakling speed for the 40m fast-paced walk test
Baseline, 2, 6 and 12 months follow-up
- +3 more secondary outcomes
Other Outcomes (1)
Number of sessions attended by the patient
2, 6, 12 months follow-up
Study Arms (3)
Standard Physical Therapy
ACTIVE COMPARATORControl group for the study. Intervention in the form of warm-up and strengthening, stretching and neuromuscular control exercises.
Intermittent Mechanical Traction
EXPERIMENTALStandard care in addition to intermittent mechanical distraction of the knee joint.
Continuous Mechanical Traction
EXPERIMENTALStandard care in addition to continuous mechanical distraction of the knee joint
Interventions
Patients assigned to this group will receive a 40-min multimodal supervised physical therapy treatment comprised of warm-up (10-min cycling/walking), muscle strengthening and stretching, and neuromuscular control exercises. Manual mobilization techniques may be applied as necessary according to the findings of the physical examination. Treating physical therapists will prescribe exercises based on a predetermined list of exercises.
In addition to the standard treatment, patients in this group will receive intermittent knee joint decompression for 20 minutes. Patients will be lying supine with the knee semiflexed to 30° and supported by a wedge under the knee. A customized leg cuff will be placed around the lower leg and two ropes will be extending horizontally from the cuff to the vertical traction weight using a pulley system to transfer the traction force to the tibiofemoral articulation. The magnitude of the traction force will be between 10-15% of the patient's body weight. The traction force will be applied for 10 application cycles; each cycle comprised of 2 minutes traction followed by 30 seconds relief. This will sum up to 20 minutes of actual joint traction duration. The traction force application and relief time will be controlled manually by the treating therapist. Knee joint traction procedures will be applied at the end of the physical therapy session.
Patients assigned to this group will receive the same treatment protocol as those in the Intermittent Mechanical Traction group. However, the knee traction force will be applied continuously for 20 minutes without intermittent force relief periods.
Eligibility Criteria
You may qualify if:
- ≥40 years of age;
- having knee pain;
- having at least three of the following additional symptoms: a-morning stiffness ≤ 30 minutes, b-crepitation, c-bone margin tenderness, d-bony enlargement or e-no palpable warmth;
- willing to provide informed consent
You may not qualify if:
- rheumatoid arthritis;
- serious pathological conditions (inflammatory arthritis and malignancy); total or partial arthroplasty of the affected knee joint, or on waiting list for joint replacement surgery;
- recent surgical procedure of the lower extremities in the previous 6 months;
- uncontrolled hypertension and unstable cardiovascular problems that could subject the participant to increased risk with exercise and physical exertion;
- physical incapability to safely perform exercises, walking or stationary cycling, as in: debilitating visual defects, neurological problems, exaggerated low back pain, advanced osteoporosis, and inability to walk 10 meters without an assistive device;
- use of prescribed analgesics, corticosteroid or analgesic injection intervention for knee pain within the previous 30 days;
- lack of clear comprehension of study procedures or inability to comply with instructions;
- stated inability to attend or complete the proposed course of intervention and follow-up schedule.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Farrag, PhD
Prince Sultan Military College of Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Both the outcome assessors and the study statistician will be blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 29, 2020
First Posted
April 2, 2020
Study Start
September 1, 2021
Primary Completion
December 1, 2022
Study Completion
December 1, 2023
Last Updated
March 10, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share